---
title: "RPC: The company has a sufficient market supply of oseltamivir phosphate capsules and other antiviral flu medications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224393889.md"
description: "RPC stated on the interactive platform that the mainstream anti-influenza product Oseltamivir Phosphate Capsules has been sold by the company for many years, and it is self-developed and self-produced, currently able to ensure market supply. In addition, for corresponding symptomatic medications for influenza, such as antipyretic and analgesic products like Renhe Ibuprofen; cough suppressants like Strong Loquat Syrup and Cough Syrup, these products are all key golden products of the company. Currently, the company's production and sales are normal, and as the year-end holiday approaches, all departments will focus on market demand to fully ensure product supply"
datetime: "2025-01-09T04:07:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224393889.md)
  - [en](https://longbridge.com/en/news/224393889.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224393889.md)
generator: "portal-rs"
---

# RPC: The company has a sufficient market supply of oseltamivir phosphate capsules and other antiviral flu medications

On January 9th, Jinshi Data reported that RPC stated on the interactive platform that the mainstream anti-influenza product Oseltamivir Phosphate Capsules has been sold by the company for many years and is self-researched and self-produced, currently ensuring market supply. Additionally, for symptoms corresponding to influenza, such as antipyretic and analgesic products like Renhe Ibuprofen; cough relief products like Strong Loquat Syrup and Cough Syrup, these products are all key gold products of the company. Currently, the company's production and sales are normal, and as the year-end holiday approaches, all departments will focus on market demand to fully ensure product supply

### Related Stocks

- [000650.CN](https://longbridge.com/en/quote/000650.CN.md)
- [002826.CN](https://longbridge.com/en/quote/002826.CN.md)
- [GLD.US](https://longbridge.com/en/quote/GLD.US.md)
- [002728.CN](https://longbridge.com/en/quote/002728.CN.md)
- [600420.CN](https://longbridge.com/en/quote/600420.CN.md)
- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)
- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)

## Related News & Research

- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [09:02 ETEvolved By Nature's Peptide Platform Used in FDA-Cleared Prescription Therapy for the Management of Atopic Dermatitis](https://longbridge.com/en/news/296496101.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**